Results 271 to 280 of about 155,399 (295)
Integrative Multiomics Identifies CD64⁺ Monocytes as Potential Contributors to Age-Related Macular Degeneration. [PDF]
Invest Ophthalmol Vis SciLi C +6 more
europepmc +1 more source
The Neurotoxic Phenotype of Macrophages from Patients with Age-Related Macular Degeneration (AMD)
, 2019 Itay Chowers +4 more
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Age-related macular degeneration
The Lancet, 2023Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces.
Robyn H, Guymer, Thomas G, Campbell
openaire +2 more sources
Age-related macular degeneration
British Journal of Hospital Medicine, 2005Age-related macular degeneration is the leading cause of irreversible loss of vision in the west, accounting for up to 50% of all blind registrations. With an ageing population age-related macular degeneration will have a discernible impact on society and the NHS.
Ahmed N, El-Amir +2 more
openaire +2 more sources
Age-Related Macular Degeneration
The Lancet, 2012Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the developed world. Despite recent advances in treatment, AMD causes considerable morbidity. For the non-ophthalmologist, a brief background on retinal structure is provided, followed by a description of the characteristic changes seen in AMD.
Khandhadia, Sam +2 more
openaire +5 more sources
Age‐Related Macular Degeneration
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013Age‐related macular degeneration ( AMD ) is the leading cause of blindness in the elderly, and the prevalence of the disease increases exponentially with every decade after age 50 years. It is a multifactorial disease involving a complex interplay of genetic, environmental, metabolic, and ...
Lily K, Cheung, Angie, Eaton
openaire +2 more sources
Wet age-related macular degeneration
Nature Reviews Drug Discovery, 2005Age-related macular degeneration (AMD) is the leading cause of irreversible visual loss in industrialized nations for those age 65 and above. The majority of patients with severe visual loss suffer from the wet form of AMD wherein there is choroidal neovascularization (CNV) and associated manifestations such as retinal pigment epithelial detachment ...
Amol D, Kulkarni, Baruch D, Kuppermann
openaire +4 more sources
Age-related macular degeneration
Insight - the Journal of the American Society of Ophthalmic Registered Nurses, 1997Age-related macular degeneration (AMD) is one of the leading causes of legal blindness among older adults. Early recognition of AMD is important because treatment can enable patients to maintain central vision longer. Nurses who understand the effects of AMD can teach their elderly patients ways to slow its progression, such as increasing consumption ...
openaire +3 more sources
Age-related macular degeneration
Aging Clinical and Experimental Research, 1993Age-related macular degeneration (AMD), a bilateral, progressive macular disease, represents the major cause of blindness among elderly people living in Western countries. Clinical features of AMD vary from the initial asymptomatic aspects, drusen and retinal pigment epithelium alterations, to severe atrophic or exudative changes in the advanced stages,
T, Segato, E, Midena, M C, Blarzino
openaire +2 more sources